Develops rebalanced immune responses and inflammatory pathways to treat serious diseases with limited therapeutic options.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
ReAlta Life Sciences is a clinical-stage biotechnology company that develops peptide-based therapies designed to regulate the body’s inflammatory and immune responses. It focuses on treating serious diseases driven by excessive or misdirected inflammation by targeting key biological pathways involved in immune activation. The company’s approach centers on restoring balance in the immune system to address conditions with limited existing treatment options.
ReAlta Life Sciences Funding
Sign up to gain insights into ReAlta Life Sciences funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series A-7 | Apr 08, 2026 | 40M | ||
| Series A-6 | Dec 18, 2024 | 25M | ||
| Series A-5 | Nov 07, 2023 | 30M | ||
| Series A-4 | Feb 22, 2023 | 12M | ||
| Series A-3 | Dec 18, 2020 | 20M | ||
| Series A | Sep 10, 2018 | 5M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
ReAlta Life Sciences Management Team
Investors
Marathon Pharma
ReAlta Life Sciences Valuations & Financials
View real-time NPM data on ReAlta Life Sciences stock including daily ReAlta Life Sciences stock price estimates, valuation history, and historical share price information. Access ReAlta Life Sciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track ReAlta Life Sciences pricing across six independent market signals. Looking for private company due diligence data sources on ReAlta Life Sciences? Get in touch to learn more.
Similar Companies
like ReAlta Life Sciences
Delix
Healthcare & Life Sciences
Biotech company develops non-hallucinogenic compounds to enhance brain plasticity and treat mental health conditions through neural repair.
Medix Infusion
Healthcare & Life Sciences
Healthcare provider delivers specialized infusion therapy services in clinics and homes, offering convenient treatment options for patients.
Truvian
Healthcare & Life Sciences
A medical technology company that creates automated blood testing analyzers, providing rapid and accurate diagnostic results to enhance patient care.
Santa Ana Bio
Healthcare & Life Sciences
Designs antibodies targeting immune dysregulation to treat autoimmune and inflammatory disease.
Jukebox Health
Healthcare & Life Sciences
Enable people that age in place through clinician-led home modifications and environmental safety upgrades.
Hillstar Bio
Healthcare & Life Sciences
Develops precision immunology treatments that selectively target pathogenic immune cells while sparing healthy ones for autoimmune disease patients.
Dominion Aesthetic Technologies
Healthcare & Life Sciences
Medical device company specializing in aesthetic technology development with focus on EON platform innovation.
Prudentia Sciences
Healthcare & Life Sciences
Technology platform that accelerates drug development through comprehensive due diligence and valuation of pharmaceutical assets to maximize ROI.
858 Therapeutics
Healthcare & Life Sciences
Develops small molecule therapeutics targeting novel oncology and immunology pathways, with lead program ETX-19477 in Phase 1 trials for solid tumors.
FAQ
We have answers
ReAlta Life Sciences stock does not trade on public stock exchanges. ReAlta Life Sciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in ReAlta Life Sciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
ReAlta Life Sciences Stock does not trade on public stock exchanges. In order to sell ReAlta Life Sciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
ReAlta Life Sciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view ReAlta Life Sciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for ReAlta Life Sciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell ReAlta Life Sciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in ReAlta Life Sciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
ReAlta Life Sciences is a private company and has not had an IPO. There is currently no ReAlta Life Sciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to ReAlta Life Sciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
